Pfizer Accupril “Branded Generic” Plans Challenged By Teva
Pfizer should be required to obtain a supplemental NDA approval for Accupril before marketing a "branded generic" version of the ACE inhibitor, Teva told FDA in a June 9 1citizen petition
Pfizer should be required to obtain a supplemental NDA approval for Accupril before marketing a "branded generic" version of the ACE inhibitor, Teva told FDA in a June 9 1citizen petition